African Society of Pharmacovigilance 2016 meeting
3rd African Society of Pharmacovigilance Conference (ASoP 2016)
“Pharmacovigilance in Africa: Successes, best practices, innovations, and lessons learned” Mombasa, Kenya, 7-9 December 2016 (Savora White Sands).
The use of a wide variety of essential medicines and health technologies in Africa creates the need for robust pharmacovigilance systems to promote patient safety across the continent. With regional variations in the status of pharmacovigilance systems, collaboration among African countries is essential, as it promotes strengthening of pharmacovigilance through sharing of lessons learned, mutual exchange of best practices and scale up with a goal of ensuring patient safety
|African Society of Pharmacovigilance 2016 meeting
|December 07-09, 2016
The African Society of Pharmacovigilance (ASoP) was launched during the 32nd WHO meeting in Rabat, Morocco in November 2009, where representatives from 16 African nations met to discuss a pharmacovigilance society for African professionals. Subsequently, ASoP became the African Chapter of the International Society of Pharmacovigilance (ISoP) during the 10th ISoP Annual Meeting in November 2010 in Accra, Ghana.
The main objectives of the African Chapter of ISoP are to develop and foster Pharmacovigilance Interventions in African countries and to promote a regular exchange of information on Pharmacovigilance issues through meetings, workshops, bulletins and trainings.
The main focus will be Pharmacovigilance in Africa: Successes, best practices, Innovations and Lessons Learned with the following sub themes:
- Achievements and lessons learned in Pharmacovigilance
- Pharmacovigilance data and Use for decision Making at all levels
- Emerging areas, new ideas and opportunities for Pharmacovigilance in Africa
- Challenges, unmet needs and strategies to advanced Pharmacovigilance in Africa
- Global Trends and efforts to coordinate and harmonize Pharmacovigilance strengthening for optimal results
Who should attend: CEO's, CTO's, CIO's, Presidents, VPs, Directors, Heads, Managers, Scientific Advisors, Consultants, Practitioners of: Pharmacovigilance Pharmacoepidemiology Pharmacogenomics Drug/Product Safety Drug Development Clinical Pharmacology Clinical Safety Quality Assurance Signal Detection Safety Surveillance Data Analysis Epidemiology Medical Affairs Regulatory Affairs And many more....
Who should attend: CEO's, CTO's, CIO's, Presidents, VPs, Directors, Heads, Managers, Scientific Advisors, Consultants, Practitioners of: